Sign inGet started

Santel Donald J

Insider CIK 1293630 · HPTX CEO & President, Director · OYST Director · AVTE Director · SRZN

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AVTE Aerovate Therapeutics, Inc A Award deriv2024-06-052024-06-0712,500— $012,500SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2024-01-022024-01-042,889$13.49 $39.0K2,889SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2023-06-062023-06-0812,500— $012,500SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2023-01-192023-01-232,519$15.48 $39.0K2,519SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2023-01-192023-01-2325,000— $025,000SEC↗
OYST Oyster Point Pharma, Inc. D To issuer deriv2023-01-032023-01-045,359— $00SEC↗
OYST Oyster Point Pharma, Inc. D To issuer deriv2023-01-032023-01-0415,170— $00SEC↗
OYST Oyster Point Pharma, Inc. D To issuer2023-01-032023-01-048,198— $00SEC↗
OYST Oyster Point Pharma, Inc. U Tender2023-01-032023-01-045,489— $08,198SEC↗
OYST Oyster Point Pharma, Inc. A Award deriv2022-06-062022-06-085,359— $05,359SEC↗
OYST Oyster Point Pharma, Inc. A Award2022-06-062022-06-083,573— $013,687SEC↗
SRZN Surrozen, Inc./DE D To issuer deriv2021-08-112021-08-1330,000— $00SEC↗
SRZN Surrozen, Inc./DE A Award2021-08-112021-08-1330,000— $030,000SEC↗
OYST Oyster Point Pharma, Inc. A Award deriv2021-07-302021-08-0310,405— $010,405SEC↗
OYST Oyster Point Pharma, Inc. A Award deriv2021-07-302021-08-034,765— $04,765SEC↗
OYST Oyster Point Pharma, Inc. A Award2021-07-302021-08-033,177— $010,114SEC↗
OYST Oyster Point Pharma, Inc. A Award2021-07-302021-08-036,937— $06,937SEC↗
HPTX HYPERION THERAPEUTICS INC D To issuer deriv2015-05-072015-05-0870,000$46.00 $3.22M0SEC↗
HPTX HYPERION THERAPEUTICS INC D To issuer deriv2015-05-072015-05-08111,000$46.00 $5.11M0SEC↗
HPTX HYPERION THERAPEUTICS INC D To issuer deriv2015-05-072015-05-08169— $00SEC↗
HPTX HYPERION THERAPEUTICS INC D To issuer deriv2015-05-072015-05-08143,000$46.00 $6.58M0SEC↗
HPTX HYPERION THERAPEUTICS INC D To issuer deriv2015-05-072015-05-0888,547$46.00 $4.07M0SEC↗
HPTX HYPERION THERAPEUTICS INC D To issuer deriv2015-05-072015-05-08303,133$46.00 $13.94M0SEC↗
HPTX HYPERION THERAPEUTICS INC D To issuer deriv2015-05-072015-05-086,648$46.00 $305.8K0SEC↗
HPTX HYPERION THERAPEUTICS INC U Tender2015-05-072015-05-0810,164$46.00 $467.5K0SEC↗
HPTX HYPERION THERAPEUTICS INC D To issuer2015-05-072015-05-08292,057$46.00 $13.43M0SEC↗
HPTX HYPERION THERAPEUTICS INC U Tender2015-05-072015-05-082,306$46.00 $106.1K0SEC↗
HPTX HYPERION THERAPEUTICS INC D To issuer2015-05-072015-05-0853,875$46.00 $2.48M0SEC↗
HPTX HYPERION THERAPEUTICS INC M Exercise deriv2015-05-012015-05-0533,242— $06,648SEC↗
HPTX HYPERION THERAPEUTICS INC M Exercise deriv2015-05-012015-05-05224,211— $0303,133SEC↗
HPTX HYPERION THERAPEUTICS INC M Exercise deriv2015-05-012015-05-0534,604— $088,547SEC↗
HPTX HYPERION THERAPEUTICS INC M Exercise2015-05-012015-05-05224,211$1.28 $287.0K280,689SEC↗
HPTX HYPERION THERAPEUTICS INC M Exercise2015-05-012015-05-0533,242$4.08 $135.6K313,931SEC↗
HPTX HYPERION THERAPEUTICS INC M Exercise2015-05-012015-05-0534,604$7.31 $253.0K348,535SEC↗
HPTX HYPERION THERAPEUTICS INC A Award deriv2015-02-092015-02-1070,000— $070,000SEC↗
HPTX HYPERION THERAPEUTICS INC A Award2015-02-092015-02-1040,000— $056,478SEC↗
HPTX HYPERION THERAPEUTICS INC F Tax w/h2015-01-022015-01-052,022$24.28 $49.1K16,478SEC↗
HPTX HYPERION THERAPEUTICS INC A Award deriv2014-03-112014-03-13111,000— $0111,000SEC↗
HPTX HYPERION THERAPEUTICS INC A Award2014-03-112014-03-1318,500— $018,500SEC↗
HPTX HYPERION THERAPEUTICS INC A Award deriv2013-04-152013-05-01143,000— $0143,000SEC↗